Advising Biotech CEOs Differently

Standing Out to Succeed

Mishal Howard-Taylor (Mishal Tariq) reading a book and David Dible working on a laptop in a bright room with large window and indoor plants at Koda Konsult HQ in Edinburgh.

  • Founder

    • Vast experience in pharmaceutical & biotechnology sectors.

    • Financially astute analyst & investor.

    • Skilled communicator with a wide network & respected stature in relevant industries.

    • With experience on all sides of the table, offers unmatched insights for growing business potential & value.

  • Strategy & Marketing

    • Versatile background spanning entrepreneurship, scientific research, strategic planning, business development & project management.

    • Well-connected within entrepreneurial ecosystems

    • Offering valuable insights & access to resources, partners & opportunities

Our Unique Synergy

Complementary Experience

Holistic view of the business landscape, combining financial acumen with cutting-edge scientific & entrepreneurial insights

Diversity of Thought

Blend of perspectives fosters creative problem-solving, strategic growth & a comprehensive understanding of the market dynamics

Broad Experience Spanning the Life Science & Entrepreneurial Landscape

Collage of various company logos, including Lonza, Transgene, Cambridge Antibody Technology, Novo Nordisk, Science Creates, Argenx, Movetis, Astra, Plug and Play, Actelion, Zentiva, Quell TX, UKRI, Biacore, Converge, IMmatics, Hutchmed, Abingworth, ARJO, Edinburgh Innovations, Autolus, Karolinska Development, and others.

David Dible - 40 Years of Lived Experience

Rated Pharmaceutical Analyst

Investor

Healthcare Banker

C Suite Management

Strategic Advisor

David Dible viewed from behind, standing on a balcony at St James Quarter in Edinburgh, looking at a the Edinburgh skyline in the distance including Edinburgh Castle and Calton Hill.

David’s Career in Numbers

  • Over 2500 companies analysed

  • 250+ CEOs advised

  • 500+ top investors advised

  • Managed $0.5 billion portfolio of public company investments

  • Managed over 100 investment analysts  - 40 nationalities

  • Supported over $10 billion of fund raising and M&A transactions

  • Supported clients that have generated over $10 billion of shareholder value, including multiple “unicorns”

How Can We Help Your Business Thrive?

Aligning the Corporate and Asset Value Creating Narratives

Positioning our life science clients to realise their full potential

A diagram comparing corporate and product equity stories with corresponding strategic and scientific support, showcasing their roles in corporate communications, investor relations, media, scientific narrative, and market strategies.

Providing Best-in-Class Solutions and Expert Insights at the Optimal Time

A timeline infographic showing stages of medical product development and commercialization. It progresses from early to late-stage clinical development with icons representing scientific, pipeline, medical affairs, and branding steps, to pre-and-post commercial launch stages with icons for creative development, evidence, and stakeholder engagement.

Let’s Work Together

Contact us for a discovery call and bespoke quote based on your requirements.

Request a Quote